[go: up one dir, main page]

ITMI20061874A1 - Composizione per il trattamento degli stati patologici neurodegenerativi del sistema nervoso centrale ed in particolare nel morbo di parkinson - Google Patents

Composizione per il trattamento degli stati patologici neurodegenerativi del sistema nervoso centrale ed in particolare nel morbo di parkinson

Info

Publication number
ITMI20061874A1
ITMI20061874A1 IT001874A ITMI20061874A ITMI20061874A1 IT MI20061874 A1 ITMI20061874 A1 IT MI20061874A1 IT 001874 A IT001874 A IT 001874A IT MI20061874 A ITMI20061874 A IT MI20061874A IT MI20061874 A1 ITMI20061874 A1 IT MI20061874A1
Authority
IT
Italy
Prior art keywords
parkinson
disease
central
treatment
composition
Prior art date
Application number
IT001874A
Other languages
English (en)
Italian (it)
Inventor
Rosario Ammirante
Felice Piero Molinari
Original Assignee
Rosario Ammirante
Felice Piero Molinari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rosario Ammirante, Felice Piero Molinari filed Critical Rosario Ammirante
Priority to IT001874A priority Critical patent/ITMI20061874A1/it
Publication of ITMI20061874A1 publication Critical patent/ITMI20061874A1/it
Priority to PCT/IB2007/002820 priority patent/WO2008038119A2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/385—Concentrates of non-alcoholic beverages
    • A23L2/39—Dry compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/10—General methods of cooking foods, e.g. by roasting or frying
    • A23L5/15—General methods of cooking foods, e.g. by roasting or frying using wave energy, irradiation, electrical means or magnetic fields, e.g. oven cooking or roasting using radiant dry heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT001874A 2006-09-29 2006-09-29 Composizione per il trattamento degli stati patologici neurodegenerativi del sistema nervoso centrale ed in particolare nel morbo di parkinson ITMI20061874A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT001874A ITMI20061874A1 (it) 2006-09-29 2006-09-29 Composizione per il trattamento degli stati patologici neurodegenerativi del sistema nervoso centrale ed in particolare nel morbo di parkinson
PCT/IB2007/002820 WO2008038119A2 (fr) 2006-09-29 2007-09-26 Composition contenant un complexe de coenzyme q10 et de cyclodextrines et son utilisation pour le traitement de pathologies du système nerveux central

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001874A ITMI20061874A1 (it) 2006-09-29 2006-09-29 Composizione per il trattamento degli stati patologici neurodegenerativi del sistema nervoso centrale ed in particolare nel morbo di parkinson

Publications (1)

Publication Number Publication Date
ITMI20061874A1 true ITMI20061874A1 (it) 2006-12-29

Family

ID=39190249

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001874A ITMI20061874A1 (it) 2006-09-29 2006-09-29 Composizione per il trattamento degli stati patologici neurodegenerativi del sistema nervoso centrale ed in particolare nel morbo di parkinson

Country Status (2)

Country Link
IT (1) ITMI20061874A1 (fr)
WO (1) WO2008038119A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU100797B1 (en) * 2018-05-15 2019-11-15 Univ Luxembourg 2-hydroxypropyl-beta-cyclodextrin for use in a method of treatment of a parkinsonian condition
FR3117339B1 (fr) 2020-12-16 2025-10-24 Naos Inst Of Life Science Utilisation des bactériorubérines et leurs dérivés glycosylés pour prévenir et traiter les maladies impliquant une dérégulation de l’agrégation des protéines, comme les maladies neurodégénératives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1532108B1 (fr) * 2002-07-29 2016-06-29 Cardax Pharma, Inc. Esters d'astaxanthin pour l'inhibition et la reduction de maladie
US7030102B1 (en) * 2003-05-06 2006-04-18 Bioactives, Llc Highly bioavailable coenzyme Q-10 cyclodextrin complex
CN1870982B (zh) * 2003-10-31 2010-05-26 株式会社钟化 含还原型辅酶q的组合物
CN1319534C (zh) * 2004-10-28 2007-06-06 昆明翔昊科技有限公司 含番茄红素和辅酶q10的制剂及其制备方法

Also Published As

Publication number Publication date
WO2008038119A2 (fr) 2008-04-03
WO2008038119A3 (fr) 2008-11-06

Similar Documents

Publication Publication Date Title
BRPI0822111A2 (pt) Uso de uma composição líquida na fabricação de uma composição para prevenir e/ou tratar declínio da memória e/ou da disfunção cognitiva, mal de alzheimer, mal de parkinson e/ou demência, composição líquida, e, composição nutricional
BRPI0817271A2 (pt) Método de tratamento da doença de parkinson e outros distúrbios relacionados
BRPI0819582A2 (pt) "sistema de tratamento de líquido"
BRPI0818799A2 (pt) Composições para o tratamento da doença de parkinson
LT2390255T (lt) Nauji aminoglikozidai ir jų panaudojimas genetinių sutrikimų gydyme
IL220684A (en) Anaphylactic therapy for Alzheimer's and the aging brain
EP2483102A4 (fr) Support d'occupant de véhicule
SI2197883T1 (sl) Derivat kateholamina uporaben za zdravljenje parkinsonove bolezni
IL195906A0 (en) Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
PL2985032T3 (pl) Glyx do stosowania do leczenia choroby alzheimera, choroby parkinsona lub choroby huntingtona
BRPI0818988A2 (pt) "chip de alimentação líquida e métodos de análise e de alimentação de líquidos"
EP2069541A4 (fr) Polymorphismes dans des genes affectant des troubles du systeme nerveux central et leurs utilisations
EP2035412A4 (fr) Agonistes du récepteur muscarinique convenant au traitement de la douleur, de la maladie d'alzheimer et de la schizophrénie
IL204584A0 (en) Compounds for use in imaging, diagnosing, and/or treatment of diseases of the central nervous system or of tumors
IL195431A0 (en) Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia
IL185300A0 (en) New pharmaceutical compositions useful in the treatment of parkinson's disease
GB0714447D0 (en) Cannabidiol for use in the treatment of neurodegenerative conditions
IL206107A0 (en) Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders
EP2214488A4 (fr) Compositions et procédés pour traiter la maladie de parkinson et des troubles associés
BR112012002077A2 (pt) processos e métodos para diagnóstico de doença de alzheimer
ITMI20061874A1 (it) Composizione per il trattamento degli stati patologici neurodegenerativi del sistema nervoso centrale ed in particolare nel morbo di parkinson
EP2285798A4 (fr) Agonistes des récepteurs muscariniques utiles dans le traitement de la douleur, de la maladie d alzheimer et de la schizophrénie
EP2517698A4 (fr) Agent pour traiter la maladie de parkinson
EP2231563A4 (fr) Catalyseur et processus d'hydrogénation des aromatiques
BRPI0714307A2 (pt) Uso de benzamidas trifluormetil-substituídas no tratamento de distúrbios neurológicos